RevMedica develops a handheld robotic laparoscopic stapler that enhances intraoperative decision-making by providing real-time adjustments and objective data during surgical procedures. This technology addresses the challenges of soft tissue management by improving patient safety and reducing waste in the operating room.
Funding
$14.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current laparoscopic stapling methods lack real-time feedback and objective data, potentially compromising intraoperative decision-making during soft tissue management. This can lead to suboptimal patient outcomes and increased waste in the operating room.
Solution
RevMedica is developing a handheld robotic laparoscopic stapler that provides surgeons with intraoperative intelligence through real-time adjustments and objective data. The system aims to optimize clinical decision-making, improve patient safety, and reduce operating room waste. The platform delivers clinical, economic, and environmental value by enhancing workflows and reducing waste, and eliminating toxic battery disposal and wasteful sterilization cycles.
Target Audience
The primary target audience includes surgeons performing laparoscopic procedures who seek enhanced control, real-time data, and improved patient outcomes during soft tissue management.
Features
- Handheld robotic design for enhanced maneuverability and precision
- Real-time data feedback to inform surgical decisions during stapling
- Objective tissue analysis to optimize staple placement and compression
- Powered stapler ergonomically designed to fit all glove sizes
- Environmentally friendly design to eliminate toxic battery disposal
- Cost-effective surgical system